GlassScriptPhysician profile
Joseph M Benson
NPI 1710979182
$923.28
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $217 · 2021: $191 · 2022: $28.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $165.15 | 2019 | |
| Abbvie INC. | $149.98 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.22 | 2019-2021 | |
| Novo Nordisk INC | $103.86 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $88.52 | 2019-2021 | |
| Allergan, INC. | $76.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $62.96 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $45.44 | 2020-2021 | |
| Biogen, INC. | $26.70 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.13 | 2019 | |
| Pfizer INC. | $15.69 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.23 | 2022 | |
| Amgen INC. | $15.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $11.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.